98 related articles for article (PubMed ID: 8066063)
21. GM-CSF therapy for delayed engraftment after autologous bone marrow transplantation.
Brandwein JM; Nayar R; Baker MA; Sutton DM; Scott JG; Sutcliffe SB; Keating A
Exp Hematol; 1991 Mar; 19(3):191-5. PubMed ID: 1995310
[TBL] [Abstract][Full Text] [Related]
22. In vitro response of normal and aplastic anemia bone marrow to mast cell growth factor and in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3.
Gibson FM; Scopes J; Daly S; Ball SE; Gordon-Smith EC
Exp Hematol; 1994 Mar; 22(3):302-12. PubMed ID: 8112428
[TBL] [Abstract][Full Text] [Related]
23. Impaired response of myelodysplastic marrow progenitors to stimulation with recombinant haemopoietic growth factors.
Merchav S; Wagemaker G; Souza LM; Tatarsky I
Leukemia; 1991 Apr; 5(4):340-6. PubMed ID: 1709245
[TBL] [Abstract][Full Text] [Related]
24. Serum concentrations of circulating endogenous granulocyte-macrophage colony-stimulating factor in HIV-1-seropositive injecting drug users.
Herold M; Meise U; Günther V; Rössler H; Zangerle R
Presse Med; 1994 Dec; 23(40):1854-8. PubMed ID: 7899316
[TBL] [Abstract][Full Text] [Related]
25. [Hematopoietic growth factors in prophylaxis and therapy of infections complications in children with neutropenia].
Lehrnbecher T
Klin Padiatr; 2001; 213(4):212-38. PubMed ID: 11528556
[TBL] [Abstract][Full Text] [Related]
26. Use of granulocyte-macrophage colony-stimulating factor in hematopoietic disorders: biology and nature of response.
Vadhan-Raj S; Broxmeyer HE; Hittelman WN
Semin Hematol; 1992 Oct; 29(4 Suppl 3):4-13. PubMed ID: 1492234
[No Abstract] [Full Text] [Related]
27. Treatment of myelodysplastic syndromes with hematopoietic growth factors.
Ganser A; Hoelzer D
Hematol Oncol Clin North Am; 1992 Jun; 6(3):633-53. PubMed ID: 1377194
[TBL] [Abstract][Full Text] [Related]
28. [Pyoderma gangrenosum aggravated by GM-CSF administration].
Perrot JL; Benoit F; Segault D; Jaubert J; Guyotat D; Claudy A
Ann Dermatol Venereol; 1992; 119(11):846-8. PubMed ID: 1301698
[No Abstract] [Full Text] [Related]
29. Clinical trials of granulocyte-macrophage colony-stimulating factor for the treatment of aplastic anemia.
Vadhan-Raj S
Immunol Ser; 1992; 57():661-70. PubMed ID: 1504150
[No Abstract] [Full Text] [Related]
30. Plasma lactoferrin content in neutropenic patients: effects of treatment with recombinant granulocyte-macrophage colony-stimulating factor.
Bezwoda WR; Dajee D
Mol Biother; 1992 Jun; 4(2):103-6. PubMed ID: 1515094
[TBL] [Abstract][Full Text] [Related]
31. GM-CSF treatment of myelodysplastic syndromes: personal experience and preliminary results of a randomized international study.
Coiffier B; Bastion Y; Felman P; Tigaud JD; Bryon PA
Pathol Biol (Paris); 1992 Nov; 39(9):957-8. PubMed ID: 1538951
[No Abstract] [Full Text] [Related]
32. [GM-CSF can reveal a latent infection].
Bastion Y; Coiffier B; Tigaud JD; Bryon PA
Presse Med; 1991 Mar; 20(10):477-8. PubMed ID: 1827183
[No Abstract] [Full Text] [Related]
33. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
[TBL] [Abstract][Full Text] [Related]
34. Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factor.
Vadhan-Raj S; Buescher S; Broxmeyer HE; LeMaistre A; Lepe-Zuniga JL; Ventura G; Jeha S; Horwitz LJ; Trujillo JM; Gillis S
N Engl J Med; 1988 Dec; 319(25):1628-34. PubMed ID: 3059191
[TBL] [Abstract][Full Text] [Related]
35. Production of granulocyte colony-stimulating factor and granulocyte/macrophage-colony-stimulating factor after interleukin-1 stimulation of marrow stromal cell cultures from normal or aplastic anemia donors.
Migliaccio AR; Migliaccio G; Adamson JW; Torok-Storb B
J Cell Physiol; 1992 Jul; 152(1):199-206. PubMed ID: 1377699
[TBL] [Abstract][Full Text] [Related]
36. Haemopoietic growth factor GM-CSF for aplastic anaemia in children.
Khan MA; Hameed A; Tahir M; Gandapur AJ; Rehman Hu; Durrani FM; Ahmad A
Lancet; 1995 Jan; 345(8943):199. PubMed ID: 7823700
[No Abstract] [Full Text] [Related]
37. In vivo recruitment of GM-CSF-response myelopoietic progenitor cells by interleukin-3 in aplastic anemia.
Herrmann F; Lindemann A; Raghavachar A; Heimpel H; Mertelsmann R
Leukemia; 1990 Oct; 4(10):671-2. PubMed ID: 2214870
[TBL] [Abstract][Full Text] [Related]
38. In vitro effect of stem cell factor on colony growth from acquired severe aplastic anemia.
Bacigalupo A; Piaggio G; Podestá M; Raffo MR; Tedone E; Sogno G; Benvenuto F; Figari O; Grassia L; Bagnara GP
Stem Cells; 1993 Jul; 11 Suppl 2():175-9. PubMed ID: 7691324
[TBL] [Abstract][Full Text] [Related]
39. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M
Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
[TBL] [Abstract][Full Text] [Related]
40. GM-CSF clinical trials: pediatric aplastic anemia and Fanconi's anemia.
Lopez KD; Guinan EC
Pediatr Nurs; 1995; 21(4):345-9. PubMed ID: 7644282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
